
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
Included in this category is the recommendation for psychosis risk syndrome.
Other disorders include those not currently listed such as catatonia specifier and those proposed for possible removal such as shared psychotic disorder as well as the paranoid, disorganized, catatonic, undifferentiated, and residualy types of schizophrenia.
Related Content
We Are All DSM5 Diagnosticians - We Are Not All Physicians
The 5-minute Phenomenologist: A Primer for Psychiatrists




